Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2013
12/17/2013US8609722 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
12/17/2013US8609146 Multi-block copolymers for the preparation of stabilized micelles
12/17/2013US8609141 Silver ion delivery platform
12/17/2013US8609119 Active agent delivery and/or odor retentive composition and methods of use thereof
12/17/2013US8609104 Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates
12/17/2013US8609091 Method for endocytic presentation of an immunosuppressive for the treatment of type 1 diabetes
12/17/2013US8609081 Cyclodextrin-based polymers for therapeutics delivery
12/17/2013US8609080 Methods and compositions for controlled release of drugs
12/17/2013US8609069 Rebaudioside C and its stereoisomers as natural product sweetness enhancers
12/17/2013CA2785694C Coated solid montelukast preparation
12/17/2013CA2782498C Tablet composition containing kampo medicinal extract and its manufacturing process
12/17/2013CA2707233C Organic-inorganic hybrid particles containing contrast agent
12/17/2013CA2674538C An insulinotropic complex using an immunoglobulin fragment
12/17/2013CA2652499C Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
12/17/2013CA2617051C Ph-controlled pulsatile delivery system, methods for preparation and use thereof
12/17/2013CA2589218C Stable crystal modifications of dotap chloride
12/17/2013CA2568993C S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor
12/17/2013CA2553254C Long-term delivery formulations and methods of use thereof
12/17/2013CA2547024C Gas-filled microvesicle assembly for contrast imaging
12/17/2013CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia
12/17/2013CA2501978C Pharmaceutical composition comprising octreotide microparticles
12/17/2013CA2427310C Imaging, diagnosis and treatment of angiogenesis-related diseases comprising ecsm4
12/17/2013CA2410883C Methods for isolating and using fungal hemolysins
12/15/2013CA2820236A1 Non-viral nanoparticle-based delivery system
12/12/2013WO2013185117A1 Prostate-specific membrane antigen antibody drug conjugates
12/12/2013WO2013185116A1 Lipids for therapeutic agent delivery formulations
12/12/2013WO2013185097A1 Ultrasound-triggerable agents for tissue engineering
12/12/2013WO2013185032A1 Nanotherapeutics for drug targeting
12/12/2013WO2013184572A1 Crystalline forms of a bruton's tyrosine kinase inhibitor
12/12/2013WO2013184514A1 Site-specific labeling methods and molecules produced thereby
12/12/2013WO2013184216A1 Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency
12/12/2013WO2013184023A1 Composition for treating multiple sclerosis (variants)
12/12/2013WO2013183778A1 Composition for mucous membranes
12/12/2013WO2013183707A1 Screening method for peptide binding to target molecule in ph-dependent manner
12/12/2013WO2013183678A1 Hair growth composition
12/12/2013WO2013183656A1 Conjugate of g-protein coupled receptor binding ligand and nucleic acid molecule
12/12/2013WO2013183407A1 Mirtazapine-containing transdermally-absorbable skin-adhesive preparation
12/12/2013WO2013183055A1 Compositions comprising apomorphine and organic acids and uses thereof
12/12/2013WO2013182990A1 Oxyclozanide-based veterinary composition for administration to the skin
12/12/2013WO2013182828A1 Aqueous dispersion of polymer particles, film-forming composition containing same and uses thereof
12/12/2013WO2013182688A1 A topical gel composition comprising an ingenol derivative and a solvent mixture
12/12/2013WO2013182683A1 Pulmonary delivery of messenger rna
12/12/2013WO2013182653A1 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
12/12/2013WO2013181934A1 Polypeptide with function of synergistic targeted diagnosis and therapy of nasopharyngeal carcinoma, nanoparticles carrying same and use thereof
12/12/2013WO2013181888A1 Environmental responsive fundamental copolymer and preparation method therefor
12/12/2013WO2013158744A3 Nanoparticles of cerium and amino acids
12/12/2013US20130331764 ANTICANCER AGENT DELIVERY SYSTEM USING pH-SENSITIVE METAL NANOPARTICLES
12/12/2013US20130331549 Hydroxyapatite-Targeting Multiarm Polymers and Conjugates Made Therefrom
12/12/2013US20130331526 Temperature-sensitive polyethylene glycol / polyester block copolymer in which bioactive functional group is introduced into side chain thereof
12/12/2013US20130331465 Fluorinated protein-based polymeric carriers
12/12/2013US20130331464 Polylactides compositions and uses thereof
12/12/2013US20130331461 Stabilized Granules Containing Glyceryl Trinitrate
12/12/2013US20130331426 pH-SENSITIVE COMPOSITIONS FOR DELIVERY OF BETA LAPACHONE AND METHODS OF USE
12/12/2013US20130331425 Polymer-sunitinib conjugates
12/12/2013US20130331361 Dosage forms of bisphosphonates
12/12/2013US20130331337 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331334 Targeted cargo protein combination therapy
12/12/2013US20130331319 Methods of delivering stable topical drug compositions
12/12/2013US20130331318 Methods of delivering stable topical drug compositions
12/12/2013US20130331314 Pharmaceutical composition for treating hcv infections
12/12/2013US20130330414 Methods and compositions for treating inflammation
12/12/2013US20130330402 Antinuclear antibody utilized as a targeting agent for pharmaceutical compounds used in the treatment of cancer and other diseases
12/12/2013US20130330401 Lipids for therapeutic agent delivery formulations
12/12/2013US20130330399 Nanoparticle-based tumor-targeted drug delivery
12/12/2013US20130330383 Ocular drug delivery system
12/12/2013US20130330381 Methods of delivering stable topical drug compositions
12/12/2013US20130330380 Topical drug delivery using phosphatidylcholine
12/12/2013US20130330379 Drug delivery compositions
12/12/2013US20130330369 Reduction Of Antibody Response Against Botulinum Neurotoxin And Variants Thereof
12/12/2013US20130330363 Method of vaccination
12/12/2013US20130330332 Treatment of pemphigus
12/12/2013US20130330309 Nutraceutical and pharmaceutical composition
12/12/2013US20130330293 Bio-nano power cells and their uses
12/12/2013CA2876148A1 Lipids for therapeutic agent delivery formulations
12/12/2013CA2876139A1 Nanotherapeutics for drug targeting
12/12/2013CA2875986A1 Crystalline forms of a bruton's tyrosine kinase inhibitor
12/12/2013CA2875975A1 Novel iminosugars and their applications
12/12/2013CA2875827A1 Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency
12/12/2013CA2875604A1 Aqueous dispersion of polymer particles, film-forming composition containing same and uses thereof
12/12/2013CA2875446A1 Compositions comprising apomorphine and organic acids and uses thereof
12/12/2013CA2874854A1 Prostate-specific membrane antigen antibody drug conjugates
12/11/2013EP2671597A1 Chimeric constructs between glioma-homing peptide and cell-penetrating peptides, gHoPe2
12/11/2013EP2671596A1 Process for producing aqueous solution containing fat-soluble substance
12/11/2013EP2671595A1 Compositions and particles containing cellulosic fibers and stabilized- and/or activated- urease inhibitors, as well as methods of making and using the same
12/11/2013EP2671594A1 Production method for adhesive patch
12/11/2013EP2671593A1 Patch preparation
12/11/2013EP2671588A1 Transdermal patch
12/11/2013EP2671587A1 Patch preparation
12/11/2013EP2671583A1 Externally-used drug for treating skin disorder and method for producing same
12/11/2013EP2671581A2 Compositions and methods for treating cancer
12/11/2013EP2671573A1 Patch and patch preparation
12/11/2013EP2671572A1 Patch and patch preparation
12/11/2013EP2671570A2 Magnetic nanoparticle, having a curie temperature which is within biocompatible temperature range, and method for preparing same
12/11/2013EP2671568A1 Dermal composition comprising polymeric reversed micelle, and method for producing same
12/11/2013EP2670780A1 Cellulose-based nanoparticles for drug delivery
12/11/2013EP2670447A1 Hyaluronic acid composition
12/11/2013EP2670441A1 Therapeutic agents with improved fibrinogen binding
12/11/2013EP2670440A1 Human antibodies and antibody-drug conjugates against cd74
12/11/2013EP2670439A1 Active principle for mitigating undesired medical conditions
12/11/2013EP2670426A2 Multimodal trail molecules and uses in cellular therapies
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 1712